Segments - Optogenetics Market by and Light Equipment (Light Emitting Diode (LED) and Laser), Actuators (Archaerhodopsin, Halorhodopsin, and Channelrhodopsin), Sensors (Membrane-gated [Mermaid], Chloride [Clomeleon], Calcium [Cameleon, Aequorin, and Others], and Others), and Applications (Retinal Disease Treatment, Neuroscience, Behavioral Tracking, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global optogenetics market size is projected to register a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to rising incidence of neurological disorders across the globe.
Optogenetics is an arising clinical technology, which includes the usage of light to control cells in living tissues, mainly neurons to support study the features of abnormal and normal brain function. It is a field of biotechnology used in healthcare domains such as behavioral science, ophthalmology, cardiology, and neuroscience.
Optogenetics technique is used by settling the genes that exhibits light-sympathetic proteins into mammalian cells, which regularly lack such proteins. Optogenetics is a resilient and highly adoptable technology in the medical division. Solicitations of optogenetics for the understanding of dysfunctional and conventional behavior is widening quickly. This technology can be used to study the underlying constituents in case of anxiety, addictions, mood disorders, memory disorders, cardiac disorders, Parkinson’s disease, epilepsy, and depression, among others.
The report on the optogenetics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Optogenetics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Light Equipment (Light Emitting Diode (LED) and Laser), Actuators (Archaerhodopsin, Halorhodopsin, and Channelrhodopsin), Sensors (Membrane-gated [Mermaid], Chloride [Clomeleon], Calcium [Cameleon, Aequorin, and Others], and Others), and Applications (Retinal Disease Treatment, Neuroscience, Behavioral Tracking, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Thorlabs Inc.; Cobolt Inc.; Coherent Inc.; Laserglow Technologies; and Scientifica |
Based on light equipment, the market is bifurcated into light emitting diode (LED) and laser. The LED segment is estimated to account for a significant market share during the forecast period. Increasing demand for LED therapies used in treatment for neurological and cutaneous diseases is driving the market segment growth. However, the laser segment is expected to grow at a steady rate in the projected timeline.
In terms of types of actuators, the optogenetics market is segregated into archaerhodopsin, halorhodopsin, and channelrhodopsin. The channelrhodopsin segment is projected to expand at a considerable CAGR during the forecast period on account of growing adoption of sedentary lifestyle and increasing number of cases regarding health disorders. They typically recognize the fast depolarization of neurons on disclosure to light through direct stimulation of ion channels.
Based on applications, the market is divided into retinal disease treatment, neuroscience, behavioral tracking, and others. The neuroscience segment is estimated to account for a significant market share during the forecast period owing to increasing spread of diseases regarding stress and tension such as depression, anxiety, memory disorder, and addictions. Moreover, rising number of neuropsychiatric disorder patients is further expected to strengthen the segment growth. In addition to examining the ordinary elaboration and activity of the nervous system, neuroscience studies disorders, diseases, and injuries that affect parts of the nervous system.
On the basis of sensors, the market is segmented into membrane-gated, chloride, calcium, and others. The membrane-gated segment consists of mermaid. The chloride segment clomeleon. The calcium segment is further divided into cameleon, aequorin, and others. The calcium segment is anticipated to expand at a rapid pace during the forecast period. Rising use of extra-cellular sensing receptor is estimated to play a vital role in the conservation of a cognitive serum ionized calcium (Ca2+) accumulation by controlling the spreading levels of parathyroid hormone.
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key share of the market during the projected period. Rising use of optogenetic devices, especially in educational and research labs is driving the market growth in the region. On the other hand, the technological advancements in the US and Canada is spurring the regional market growth.
Key players competing in the global Optogenetics market are Thorlabs Inc.; Cobolt Inc.; Coherent Inc.; Laserglow Technologies; and Scientifica. Companies are focusing on partnering with local manufacturers and collaborating with other industry players to expand their market share.